Liraglutide

Trade Name: 
Victoza
Manufacturer/Distributor: 
Novo Nordisk
Classification: 
Incretin mimetic agent
Human glucagon like peptide-1
ATC Class: 
A10BX07 Liraglutide
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2010/05/21
Date Marketed in Canada (yyyy/mm/dd): 
2010/05/27
Presentation: 
Injection: 6 mg/mL; DIN: 02351064
Comments: 
For once-daily use in adults with type-2 diabetes when used in combination with metformin or metformin plus a sulfonylurea.
Source: 
Product monograph